Our findings shed light on the potential engagement of DDR genetic aberrations and the clinicopathologic relevance of the heightened expression of γ-H2AX and 53BP1 in GISTs, which represent useful biomarkers of aggressiveness in tumor evolution and aid in distinguishing cases at risk of progression. The gene discussed is H2AX; the disease is neoplasm.